Markets · bedrock market · provisional

Clinical Trial Sponsors (drug pipelines)

Regulated market (drugs@fda application holders) + trial-register participation (clinicaltrials.gov, eu ctis) + standards-body membership (cdisc). The Kin Score Market layer reads each provider in its market: who it integrates with, how deep those integrations go, and where the market publishes its own structure. Methodology.

55providers measured
0 (0.0%)declare their own
0 (0.0%)covered by others only
55 (100.0%)undeclared
0in-market workflows shown
Provisional. Provisional and unweighted: the Market layer is not part of the composite or agent readiness. Leader lists are read within a position, never as one ranking. A provider that declares nothing we can read is shown as undeclared, with no number: we never infer integrations.

Where this market publishes its structure

Own = declares at least one integration itself; covered = visible only because an aggregator, standards body, regulator or partner contract names it; distribution-only = listed only on cloud marketplaces it sells through, a channel reported beside, never counted as its own declared integrations; undeclared = nothing we can read, so no number; declares_compatibility = providers with a `compatible` shape vote, report only (kin, 2026-10-13): never counted as own, never in depth or position.

Taxonomy how this market maps onto apis.io

Derived 2026-10-22 from the 55 providers in this market we could resolve in the catalog. The percentage is the share of those providers carrying each one; it describes the market, not the tag or industry. Tag groups have no page of their own yet, so they are listed unlinked.

TagsPharmaceuticals 71%, Healthcare 65%, Life Sciences 64%, Biotechnology 55%, Clinical Trials 40%, Oncology 24%
Tag groupsHealthcare 96%, Health 25%
IndustriesBiotechnology & Drug Discovery 80%, Pharmaceutical 76%, Healthcare 71%, Life Sciences 64%, Digital Health & Telehealth 33%

share of resolved cohort carrying it; tags >=0.20 & >=3 members (max 12, junk dropped), tag_groups >=0.20 (cooccurrence, non-cross-cutting; max 8), industries >=0.20 (max 6), areas >=0.10 (max 6; areas are keyword-matched and sparse), capabilities L1 >=0.20 (max 8); derive-market-taxonomy.py

Leaders by position (provisional)

Provisional: grouped by position, depth compared within a position only. Distribution (cloud marketplaces) and iPaaS bridges are counted beside position, never inside it. Unknown-builder listings are left out of position shares and counted here.

undeclared 55 · declares nothing we can read: no number

ProviderDepthIntegrationsIn / outUnknown builderDistributioniPaaS bridgeMix
A2 Biotherapeutics undeclared-----
AbbVie undeclared-----
Abcuro undeclared-----
ADARx Pharmaceuticals undeclared-----
ADC Therapeutics undeclared-----
AiCure undeclared-----
Alloplex Biotherapeutics undeclared-----
Amgen undeclared-----
Apogee Therapeutics undeclared-----
AstraZeneca undeclared-----
Bayer undeclared-----
Beacon Biosignals undeclared-----
Biogen undeclared-----
Bristol Myers Squibb undeclared-----
Celgene undeclared-----
Chimerix undeclared-----
CIONIC undeclared-----
Denali Therapeutics undeclared-----
Eli Lilly undeclared-----
Endeavor BioMedicines undeclared-----
Engrail Therapeutics undeclared-----
Epizyme undeclared-----
Genentech undeclared-----
Gilead Sciences undeclared-----
Hospira undeclared-----
Huma undeclared-----
Insmed undeclared-----
Intersect ENT undeclared-----
JenaValve Technology undeclared-----
Johnson & Johnson undeclared-----
Life Biosciences undeclared-----
Merck undeclared-----
Neomorph undeclared-----
Neurelis undeclared-----
NeuroTherapia undeclared-----
Novartis undeclared-----
Novo Nordisk undeclared-----
Orapharma undeclared-----
Organon undeclared-----
Pfizer undeclared-----
ReCode Therapeutics undeclared-----
Regeneron undeclared-----
Revolution Medicines undeclared-----
Sanofi undeclared-----
Schrödinger undeclared-----
Scimar undeclared-----
Sibel Health undeclared-----
Strata Oncology undeclared-----
Sunshine Lake Pharma undeclared-----
Tune Therapeutics undeclared-----
Vera Therapeutics undeclared-----
Verastem undeclared-----
Verily Life Sciences undeclared-----
Viatris undeclared-----
Zurex Pharma undeclared-----

Generated 2026-10-22 from API Evangelist's own files; nothing on this page is a model's judgement. Provisional and unweighted; not part of the Kin Score composite or agent readiness. Read the Market layer methodology. Disagree with an edge? Every edge cites its evidence and can be corrected through the normal correction path.